L567-0131 Screening compound: 3-methyl-N-[(2-methylphenyl)methyl]-1-[4-(propan-2-yl)benzenesulfonyl]piperidine-3-carboxamide

L567-0131 Screening compound: 3-methyl-N-[(2-methylphenyl)methyl]-1-[4-(propan-2-yl)benzenesulfonyl]piperidine-3-carboxamide
L567-0131 Screening compound: 3-methyl-N-[(2-methylphenyl)methyl]-1-[4-(propan-2-yl)benzenesulfonyl]piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L567-0131
3-methyl-N-[(2-methylphenyl)methyl]-1-[4-(propan-2-yl)benzenesulfonyl]piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L567-0131

Molecular Formula

C24H32N2O3S (C24 H32 N2 O3 S)

Compound Name

3-methyl-N-[(2-methylphenyl)methyl]-1-[4-(propan-2-yl)benzenesulfonyl]piperidine-3-carboxamide

IUPAC name

3-methyl-N-[(2-methylphenyl)methyl]-1-[4-(propan-2-yl)benzenesulfonyl]piperidine-3-carboxamide

SMILES

CC(C)c(cc1)ccc1S(N(CCC1)CC1(C)C(NCc1c(C)cccc1)=O)(=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

428.6

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.214

Distribution Coefficient, logD

5.214

Water Solubility, LogSw

-4.95

Polar Surface Area

56.296

Acid Dissociation Constant (pKa)

10.99

Base Dissociation Constant (pKb)

-2.93

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

45.80

L567-0131 in Drug Discovery

Included in Screening Libraries

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Epigenetic
  • PPI modulators
Structure:
  • Mimetics
Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others

References: we are preparing a list of scientific research reports with L567-0131 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L567-0131?
Check Price and Availability of L567-0131, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L567-0131 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L567-0131
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L567-0131
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L567-0131 available by request